

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of guanylate cyclase activity (GO:0031282) | 5.18895355 |
| 2 | drug catabolic process (GO:0042737) | 4.86781369 |
| 3 | epoxygenase P450 pathway (GO:0019373) | 4.83993310 |
| 4 | exogenous drug catabolic process (GO:0042738) | 4.65097160 |
| 5 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.56268348 |
| 6 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.50809989 |
| 7 | positive regulation of respiratory burst (GO:0060267) | 4.43290431 |
| 8 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.32719602 |
| 9 | positive regulation of guanylate cyclase activity (GO:0031284) | 4.23124247 |
| 10 | angiotensin maturation (GO:0002003) | 4.21945754 |
| 11 | intestinal absorption (GO:0050892) | 4.04337118 |
| 12 | drug metabolic process (GO:0017144) | 3.97587691 |
| 13 | flavonoid metabolic process (GO:0009812) | 3.96433165 |
| 14 | regulation of cellular extravasation (GO:0002691) | 3.85349248 |
| 15 | alkaloid metabolic process (GO:0009820) | 3.81347780 |
| 16 | regulation of triglyceride catabolic process (GO:0010896) | 3.75736764 |
| 17 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.74535677 |
| 18 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.71387967 |
| 19 | arginine metabolic process (GO:0006525) | 3.69559815 |
| 20 | diacylglycerol metabolic process (GO:0046339) | 3.66877663 |
| 21 | ethanol oxidation (GO:0006069) | 3.57577334 |
| 22 | L-fucose catabolic process (GO:0042355) | 3.53061367 |
| 23 | fucose catabolic process (GO:0019317) | 3.53061367 |
| 24 | L-fucose metabolic process (GO:0042354) | 3.53061367 |
| 25 | bile acid and bile salt transport (GO:0015721) | 3.49202554 |
| 26 | cellular glucuronidation (GO:0052695) | 3.40142420 |
| 27 | glucuronate metabolic process (GO:0019585) | 3.39651458 |
| 28 | uronic acid metabolic process (GO:0006063) | 3.39651458 |
| 29 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.38587164 |
| 30 | negative regulation of cell killing (GO:0031342) | 3.38587164 |
| 31 | regulation of bile acid biosynthetic process (GO:0070857) | 3.33201880 |
| 32 | regulation of respiratory burst (GO:0060263) | 3.22923815 |
| 33 | arginine catabolic process (GO:0006527) | 3.22126172 |
| 34 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.18966100 |
| 35 | oxidative demethylation (GO:0070989) | 3.14512670 |
| 36 | cytidine metabolic process (GO:0046087) | 3.08405890 |
| 37 | cytidine catabolic process (GO:0006216) | 3.08405890 |
| 38 | cytidine deamination (GO:0009972) | 3.08405890 |
| 39 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.07099281 |
| 40 | killing of cells of other organism (GO:0031640) | 3.06994953 |
| 41 | disruption of cells of other organism (GO:0044364) | 3.06994953 |
| 42 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 3.06832357 |
| 43 | ethanol metabolic process (GO:0006067) | 3.06137500 |
| 44 | glycerol metabolic process (GO:0006071) | 3.04920183 |
| 45 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.00665655 |
| 46 | sulfate transmembrane transport (GO:1902358) | 3.00646796 |
| 47 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 2.99149336 |
| 48 | endocrine process (GO:0050886) | 2.99149336 |
| 49 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 2.99149336 |
| 50 | regulation of cGMP biosynthetic process (GO:0030826) | 2.98140968 |
| 51 | complement activation, classical pathway (GO:0006958) | 2.97186232 |
| 52 | fucosylation (GO:0036065) | 2.96175351 |
| 53 | phenylpropanoid metabolic process (GO:0009698) | 2.90506952 |
| 54 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.89606813 |
| 55 | indole-containing compound catabolic process (GO:0042436) | 2.80128973 |
| 56 | indolalkylamine catabolic process (GO:0046218) | 2.80128973 |
| 57 | tryptophan catabolic process (GO:0006569) | 2.80128973 |
| 58 | sulfation (GO:0051923) | 2.79812137 |
| 59 | regulation of systemic arterial blood pressure (GO:0003073) | 2.79732309 |
| 60 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 2.74468967 |
| 61 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.71761593 |
| 62 | vitamin transmembrane transport (GO:0035461) | 2.71454691 |
| 63 | activated T cell proliferation (GO:0050798) | 2.71152835 |
| 64 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 2.68977633 |
| 65 | positive regulation of antigen processing and presentation (GO:0002579) | 2.68570843 |
| 66 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.66016973 |
| 67 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.66016973 |
| 68 | high-density lipoprotein particle remodeling (GO:0034375) | 2.65859911 |
| 69 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.65475880 |
| 70 | hormone catabolic process (GO:0042447) | 2.64304679 |
| 71 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 2.62513811 |
| 72 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.57835842 |
| 73 | alditol metabolic process (GO:0019400) | 2.56754180 |
| 74 | bile acid metabolic process (GO:0008206) | 2.56543494 |
| 75 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 2.54704124 |
| 76 | indolalkylamine metabolic process (GO:0006586) | 2.54166095 |
| 77 | digestion (GO:0007586) | 2.54116940 |
| 78 | complement activation (GO:0006956) | 2.53161219 |
| 79 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.53141177 |
| 80 | phosphatidylcholine acyl-chain remodeling (GO:0036151) | 2.52202137 |
| 81 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.52140434 |
| 82 | lipoprotein transport (GO:0042953) | 2.51473879 |
| 83 | transepithelial transport (GO:0070633) | 2.50561012 |
| 84 | plasma lipoprotein particle remodeling (GO:0034369) | 2.49013273 |
| 85 | protein-lipid complex remodeling (GO:0034368) | 2.49013273 |
| 86 | macromolecular complex remodeling (GO:0034367) | 2.49013273 |
| 87 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.48746536 |
| 88 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.46573664 |
| 89 | cellular ketone body metabolic process (GO:0046950) | 2.46223822 |
| 90 | sulfate transport (GO:0008272) | 2.46191279 |
| 91 | positive regulation of fatty acid transport (GO:2000193) | 2.45197414 |
| 92 | regulation of cGMP metabolic process (GO:0030823) | 2.44701939 |
| 93 | plasma lipoprotein particle assembly (GO:0034377) | 2.42555732 |
| 94 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.42219359 |
| 95 | phosphatidylcholine metabolic process (GO:0046470) | 2.42134205 |
| 96 | negative regulation of T cell differentiation in thymus (GO:0033085) | 2.41222340 |
| 97 | epithelial structure maintenance (GO:0010669) | 2.40791814 |
| 98 | antibacterial humoral response (GO:0019731) | 2.39127651 |
| 99 | omega-hydroxylase P450 pathway (GO:0097267) | 2.38980362 |
| 100 | regulation of protein glycosylation (GO:0060049) | 2.38884832 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.24156577 |
| 2 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.80787974 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.34011184 |
| 4 | VDR_22108803_ChIP-Seq_LS180_Human | 2.25764491 |
| 5 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.17975754 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.06727468 |
| 7 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.95725393 |
| 8 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.94929957 |
| 9 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.83929157 |
| 10 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.79811491 |
| 11 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.79190462 |
| 12 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.71665170 |
| 13 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.61908039 |
| 14 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.56778294 |
| 15 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.56380953 |
| 16 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.53857036 |
| 17 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.53630795 |
| 18 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.51733236 |
| 19 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.47470103 |
| 20 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.47444838 |
| 21 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.46771171 |
| 22 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.41255384 |
| 23 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.41132057 |
| 24 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.37274561 |
| 25 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.35817543 |
| 26 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.33513238 |
| 27 | * NANOG_20526341_ChIP-Seq_ESCs_Human | 1.29959562 |
| 28 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29516407 |
| 29 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.28107201 |
| 30 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.27278953 |
| 31 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.20841791 |
| 32 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.20067418 |
| 33 | * ERA_21632823_ChIP-Seq_H3396_Human | 1.19319770 |
| 34 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.18762930 |
| 35 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.17336856 |
| 36 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.17301805 |
| 37 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.15541940 |
| 38 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.15305849 |
| 39 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.15260199 |
| 40 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.15260199 |
| 41 | * TAF2_19829295_ChIP-Seq_ESCs_Human | 1.14972571 |
| 42 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.14547488 |
| 43 | * GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.13391635 |
| 44 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.13210844 |
| 45 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.12549947 |
| 46 | GATA3_26560356_Chip-Seq_TH2_Human | 1.12200959 |
| 47 | * MYC_19829295_ChIP-Seq_ESCs_Human | 1.11978714 |
| 48 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.11931320 |
| 49 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.11615843 |
| 50 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.10862232 |
| 51 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.10664210 |
| 52 | AR_20517297_ChIP-Seq_VCAP_Human | 1.09971821 |
| 53 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.08234251 |
| 54 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.08102141 |
| 55 | P53_21459846_ChIP-Seq_SAOS-2_Human | 1.08056569 |
| 56 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.05625015 |
| 57 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.04230418 |
| 58 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.04200684 |
| 59 | * E2F1_20622854_ChIP-Seq_HELA_Human | 1.03105192 |
| 60 | * CDX2_22108803_ChIP-Seq_LS180_Human | 1.02542610 |
| 61 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.02445169 |
| 62 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.02379642 |
| 63 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.01721256 |
| 64 | P300_27268052_Chip-Seq_Bcells_Human | 1.01634005 |
| 65 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 1.00926624 |
| 66 | NCOR_22424771_ChIP-Seq_293T_Human | 1.00793656 |
| 67 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.00667832 |
| 68 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.00569227 |
| 69 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.00516046 |
| 70 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.00303665 |
| 71 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.98763908 |
| 72 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.98212830 |
| 73 | SA1_27219007_Chip-Seq_Bcells_Human | 0.94932382 |
| 74 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.94594329 |
| 75 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.94486802 |
| 76 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.93244548 |
| 77 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.93216204 |
| 78 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.93043504 |
| 79 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.92671206 |
| 80 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.92203471 |
| 81 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.92191440 |
| 82 | RXR_22108803_ChIP-Seq_LS180_Human | 0.91815374 |
| 83 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.91775885 |
| 84 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.90536413 |
| 85 | * HOXB7_26014856_ChIP-Seq_BT474_Human | 0.90220117 |
| 86 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.89431001 |
| 87 | MYB_26560356_Chip-Seq_TH2_Human | 0.89212434 |
| 88 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.87609136 |
| 89 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.87068478 |
| 90 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.86793571 |
| 91 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.85805456 |
| 92 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.85591464 |
| 93 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.85449514 |
| 94 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.85359004 |
| 95 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.84120938 |
| 96 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.84084509 |
| 97 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.83660219 |
| 98 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.83566786 |
| 99 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.83251539 |
| 100 | GATA1_22025678_ChIP-Seq_K562_Human | 0.83224651 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 5.24686480 |
| 2 | MP0005085_abnormal_gallbladder_physiolo | 3.75376320 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 3.50156313 |
| 4 | MP0005365_abnormal_bile_salt | 3.17559610 |
| 5 | MP0001666_abnormal_nutrient_absorption | 3.09733599 |
| 6 | MP0002876_abnormal_thyroid_physiology | 2.82415582 |
| 7 | MP0008875_abnormal_xenobiotic_pharmacok | 2.65841763 |
| 8 | MP0010155_abnormal_intestine_physiology | 2.60275456 |
| 9 | MP0003866_abnormal_defecation | 2.59668168 |
| 10 | MP0004147_increased_porphyrin_level | 2.52788048 |
| 11 | MP0004043_abnormal_pH_regulation | 2.52682764 |
| 12 | MP0001873_stomach_inflammation | 2.52533244 |
| 13 | MP0002138_abnormal_hepatobiliary_system | 2.36186894 |
| 14 | MP0003252_abnormal_bile_duct | 2.27843415 |
| 15 | MP0003183_abnormal_peptide_metabolism | 2.26891231 |
| 16 | MP0004019_abnormal_vitamin_homeostasis | 2.20781820 |
| 17 | MP0010329_abnormal_lipoprotein_level | 2.14347002 |
| 18 | MP0003195_calcinosis | 2.14334637 |
| 19 | MP0005671_abnormal_response_to | 2.11362440 |
| 20 | MP0004264_abnormal_extraembryonic_tissu | 2.02656678 |
| 21 | MP0003724_increased_susceptibility_to | 1.97501516 |
| 22 | MP0008872_abnormal_physiological_respon | 1.95828384 |
| 23 | MP0001800_abnormal_humoral_immune | 1.76283134 |
| 24 | MP0001835_abnormal_antigen_presentation | 1.74640447 |
| 25 | MP0000685_abnormal_immune_system | 1.73578979 |
| 26 | MP0009785_altered_susceptibility_to | 1.72472168 |
| 27 | MP0005387_immune_system_phenotype | 1.71969780 |
| 28 | MP0001790_abnormal_immune_system | 1.71969780 |
| 29 | MP0003787_abnormal_imprinting | 1.58257397 |
| 30 | MP0001664_abnormal_digestion | 1.57376480 |
| 31 | MP0001663_abnormal_digestive_system | 1.56280035 |
| 32 | MP0001765_abnormal_ion_homeostasis | 1.52266370 |
| 33 | MP0005025_abnormal_response_to | 1.47537421 |
| 34 | MP0009643_abnormal_urine_homeostasis | 1.46776805 |
| 35 | MP0005332_abnormal_amino_acid | 1.46733102 |
| 36 | MP0001501_abnormal_sleep_pattern | 1.45740791 |
| 37 | MP0001764_abnormal_homeostasis | 1.44439103 |
| 38 | MP0001986_abnormal_taste_sensitivity | 1.44319785 |
| 39 | MP0003763_abnormal_thymus_physiology | 1.38104578 |
| 40 | MP0003436_decreased_susceptibility_to | 1.37442955 |
| 41 | MP0005670_abnormal_white_adipose | 1.27666581 |
| 42 | MP0005636_abnormal_mineral_homeostasis | 1.24172196 |
| 43 | MP0002723_abnormal_immune_serum | 1.22921581 |
| 44 | MP0009379_abnormal_foot_pigmentation | 1.21858260 |
| 45 | MP0002136_abnormal_kidney_physiology | 1.21602521 |
| 46 | MP0001485_abnormal_pinna_reflex | 1.21516515 |
| 47 | MP0002118_abnormal_lipid_homeostasis | 1.20877718 |
| 48 | MP0001845_abnormal_inflammatory_respons | 1.20062424 |
| 49 | MP0005000_abnormal_immune_tolerance | 1.11829884 |
| 50 | MP0002166_altered_tumor_susceptibility | 1.10607013 |
| 51 | MP0005645_abnormal_hypothalamus_physiol | 1.09357228 |
| 52 | MP0003868_abnormal_feces_composition | 1.08691856 |
| 53 | MP0002452_abnormal_antigen_presenting | 1.07996274 |
| 54 | MP0009840_abnormal_foam_cell | 1.07934555 |
| 55 | MP0003879_abnormal_hair_cell | 1.07420133 |
| 56 | MP0009764_decreased_sensitivity_to | 1.07405065 |
| 57 | MP0001819_abnormal_immune_cell | 1.07367482 |
| 58 | MP0005448_abnormal_energy_balance | 1.06705421 |
| 59 | MP0002420_abnormal_adaptive_immunity | 1.05860912 |
| 60 | MP0004782_abnormal_surfactant_physiolog | 1.04971196 |
| 61 | MP0005310_abnormal_salivary_gland | 1.03297210 |
| 62 | MP0000230_abnormal_systemic_arterial | 1.01630166 |
| 63 | MP0000609_abnormal_liver_physiology | 1.01510236 |
| 64 | MP0005381_digestive/alimentary_phenotyp | 1.00687914 |
| 65 | MP0000477_abnormal_intestine_morphology | 1.00575208 |
| 66 | MP0003045_fibrosis | 0.97617482 |
| 67 | MP0005551_abnormal_eye_electrophysiolog | 0.97485223 |
| 68 | MP0000427_abnormal_hair_cycle | 0.95336698 |
| 69 | MP0008469_abnormal_protein_level | 0.93818844 |
| 70 | MP0005166_decreased_susceptibility_to | 0.93277973 |
| 71 | MP0001756_abnormal_urination | 0.91711711 |
| 72 | MP0006082_CNS_inflammation | 0.91634385 |
| 73 | MP0005535_abnormal_body_temperature | 0.89181030 |
| 74 | MP0002148_abnormal_hypersensitivity_rea | 0.87528806 |
| 75 | MP0002933_joint_inflammation | 0.87406761 |
| 76 | MP0002132_abnormal_respiratory_system | 0.87142598 |
| 77 | MP0003011_delayed_dark_adaptation | 0.86218243 |
| 78 | MP0005377_hearing/vestibular/ear_phenot | 0.84426150 |
| 79 | MP0003878_abnormal_ear_physiology | 0.84426150 |
| 80 | MP0009642_abnormal_blood_homeostasis | 0.82136862 |
| 81 | MP0009333_abnormal_splenocyte_physiolog | 0.81273290 |
| 82 | MP0008775_abnormal_heart_ventricle | 0.81132022 |
| 83 | MP0002638_abnormal_pupillary_reflex | 0.80400528 |
| 84 | MP0000716_abnormal_immune_system | 0.80203631 |
| 85 | MP0002102_abnormal_ear_morphology | 0.78432443 |
| 86 | MP0000538_abnormal_urinary_bladder | 0.76025579 |
| 87 | MP0002277_abnormal_respiratory_mucosa | 0.75734426 |
| 88 | MP0002419_abnormal_innate_immunity | 0.75572872 |
| 89 | MP0003646_muscle_fatigue | 0.74092381 |
| 90 | MP0003638_abnormal_response/metabolism_ | 0.73303739 |
| 91 | MP0000678_abnormal_parathyroid_gland | 0.72842602 |
| 92 | MP0005319_abnormal_enzyme/_coenzyme | 0.70268470 |
| 93 | MP0004484_altered_response_of | 0.68665865 |
| 94 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.68313284 |
| 95 | MP0002078_abnormal_glucose_homeostasis | 0.66898844 |
| 96 | MP0003806_abnormal_nucleotide_metabolis | 0.65770358 |
| 97 | MP0001533_abnormal_skeleton_physiology | 0.65500944 |
| 98 | MP0004947_skin_inflammation | 0.65344966 |
| 99 | MP0001188_hyperpigmentation | 0.64609805 |
| 100 | MP0005174_abnormal_tail_pigmentation | 0.64373258 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 5.14820004 |
| 2 | Decreased circulating renin level (HP:0003351) | 4.10116016 |
| 3 | Malnutrition (HP:0004395) | 3.68929876 |
| 4 | Hydroxyprolinuria (HP:0003080) | 3.43307647 |
| 5 | Abnormality of proline metabolism (HP:0010907) | 3.43307647 |
| 6 | Chronic diarrhea (HP:0002028) | 3.39097248 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 3.38109830 |
| 8 | Stomach cancer (HP:0012126) | 3.33801119 |
| 9 | Abnormality of renin-angiotensin system (HP:0000847) | 3.21322271 |
| 10 | Hyperactive renin-angiotensin system (HP:0000841) | 3.13728928 |
| 11 | Alkalosis (HP:0001948) | 3.10451545 |
| 12 | Congenital stationary night blindness (HP:0007642) | 3.06569523 |
| 13 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.06563032 |
| 14 | Metabolic alkalosis (HP:0200114) | 3.00635142 |
| 15 | Systemic lupus erythematosus (HP:0002725) | 2.99692659 |
| 16 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.98407282 |
| 17 | Abnormality of B cell number (HP:0010975) | 2.85297796 |
| 18 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.78382827 |
| 19 | Pigmentary retinal degeneration (HP:0001146) | 2.75944006 |
| 20 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.72023028 |
| 21 | Abnormality of vitamin B metabolism (HP:0004340) | 2.71564057 |
| 22 | Recurrent bronchitis (HP:0002837) | 2.69638098 |
| 23 | Pustule (HP:0200039) | 2.65690681 |
| 24 | Ileus (HP:0002595) | 2.62709835 |
| 25 | Abnormality of the renal cortex (HP:0011035) | 2.60660311 |
| 26 | Hyperventilation (HP:0002883) | 2.58289510 |
| 27 | Alveolar cell carcinoma (HP:0006519) | 2.57235198 |
| 28 | Confusion (HP:0001289) | 2.55761894 |
| 29 | Congenital sensorineural hearing impairment (HP:0008527) | 2.51029663 |
| 30 | Widely patent fontanelles and sutures (HP:0004492) | 2.39563120 |
| 31 | Eczematoid dermatitis (HP:0000976) | 2.39025436 |
| 32 | Hyperglycinuria (HP:0003108) | 2.37619529 |
| 33 | Hypochromic anemia (HP:0001931) | 2.37429281 |
| 34 | Panhypogammaglobulinemia (HP:0003139) | 2.37391262 |
| 35 | Abnormality of urine glucose concentration (HP:0011016) | 2.34929146 |
| 36 | Glycosuria (HP:0003076) | 2.34929146 |
| 37 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.33335468 |
| 38 | Complement deficiency (HP:0004431) | 2.31526814 |
| 39 | Myositis (HP:0100614) | 2.30090356 |
| 40 | Acanthocytosis (HP:0001927) | 2.27600340 |
| 41 | Chronic sinusitis (HP:0011109) | 2.27101255 |
| 42 | Encephalitis (HP:0002383) | 2.24659658 |
| 43 | Renal cortical cysts (HP:0000803) | 2.24402105 |
| 44 | Recurrent fungal infections (HP:0002841) | 2.23203878 |
| 45 | Vasculitis (HP:0002633) | 2.21595679 |
| 46 | Pancreatic cysts (HP:0001737) | 2.19989917 |
| 47 | Orchitis (HP:0100796) | 2.19463516 |
| 48 | Abnormality of T cell number (HP:0011839) | 2.18453910 |
| 49 | Gastrointestinal infarctions (HP:0005244) | 2.18368995 |
| 50 | Abnormality of T cells (HP:0002843) | 2.17884021 |
| 51 | Abnormality of glycine metabolism (HP:0010895) | 2.17760079 |
| 52 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.17760079 |
| 53 | Optic neuritis (HP:0100653) | 2.16994632 |
| 54 | Retrobulbar optic neuritis (HP:0100654) | 2.16994632 |
| 55 | Abnormality of vitamin metabolism (HP:0100508) | 2.14846597 |
| 56 | Bronchitis (HP:0012387) | 2.11620029 |
| 57 | Abnormality of T cell physiology (HP:0011840) | 2.11556326 |
| 58 | Cerebral palsy (HP:0100021) | 2.10646504 |
| 59 | Molar tooth sign on MRI (HP:0002419) | 2.08883496 |
| 60 | Abnormality of midbrain morphology (HP:0002418) | 2.08883496 |
| 61 | Conjugated hyperbilirubinemia (HP:0002908) | 2.08042653 |
| 62 | Hyperlipoproteinemia (HP:0010980) | 2.05202733 |
| 63 | Chronic otitis media (HP:0000389) | 2.05104707 |
| 64 | Proximal tubulopathy (HP:0000114) | 2.04589203 |
| 65 | B lymphocytopenia (HP:0010976) | 2.04507168 |
| 66 | Thyroiditis (HP:0100646) | 2.00659546 |
| 67 | Glomerulonephritis (HP:0000099) | 2.00090841 |
| 68 | Abnormality of chloride homeostasis (HP:0011422) | 1.99539244 |
| 69 | Recurrent sinusitis (HP:0011108) | 1.98529931 |
| 70 | Fat malabsorption (HP:0002630) | 1.98426013 |
| 71 | Potter facies (HP:0002009) | 1.98170360 |
| 72 | Facial shape deformation (HP:0011334) | 1.98170360 |
| 73 | Xanthomatosis (HP:0000991) | 1.95039621 |
| 74 | Prolonged partial thromboplastin time (HP:0003645) | 1.92869332 |
| 75 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.92263559 |
| 76 | Poikilocytosis (HP:0004447) | 1.91265632 |
| 77 | Delayed CNS myelination (HP:0002188) | 1.90762046 |
| 78 | Hemoptysis (HP:0002105) | 1.89041301 |
| 79 | Chronic hepatic failure (HP:0100626) | 1.88546681 |
| 80 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.88168472 |
| 81 | Bronchiectasis (HP:0002110) | 1.87818551 |
| 82 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.87544631 |
| 83 | Recurrent cutaneous fungal infections (HP:0011370) | 1.87544631 |
| 84 | Meningitis (HP:0001287) | 1.87317345 |
| 85 | Hemorrhage of the eye (HP:0011885) | 1.86835227 |
| 86 | Abolished electroretinogram (ERG) (HP:0000550) | 1.86747245 |
| 87 | Abnormal albumin level (HP:0012116) | 1.85322853 |
| 88 | Hypoalbuminemia (HP:0003073) | 1.85322853 |
| 89 | IgG deficiency (HP:0004315) | 1.85145882 |
| 90 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.85055858 |
| 91 | Villous atrophy (HP:0011473) | 1.85055858 |
| 92 | Hypochromic microcytic anemia (HP:0004840) | 1.84181435 |
| 93 | Agammaglobulinemia (HP:0004432) | 1.84105024 |
| 94 | Metabolic acidosis (HP:0001942) | 1.83985871 |
| 95 | Pancreatitis (HP:0001733) | 1.82431903 |
| 96 | T lymphocytopenia (HP:0005403) | 1.80409544 |
| 97 | Tubular atrophy (HP:0000092) | 1.80234402 |
| 98 | Nephritis (HP:0000123) | 1.79615643 |
| 99 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.79184407 |
| 100 | Abnormality of eosinophils (HP:0001879) | 1.79133438 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ACVR1B | 4.21880708 |
| 2 | FRK | 3.92191965 |
| 3 | MAP4K1 | 2.97477306 |
| 4 | TAOK3 | 2.49333888 |
| 5 | MST1R | 2.46800632 |
| 6 | TXK | 2.45857989 |
| 7 | WNK4 | 2.34039544 |
| 8 | ERN1 | 2.33071009 |
| 9 | MATK | 2.14662710 |
| 10 | STK39 | 2.08788862 |
| 11 | PIK3CA | 2.08110236 |
| 12 | FGFR4 | 2.01845713 |
| 13 | BMPR1B | 1.84867634 |
| 14 | OXSR1 | 1.83668045 |
| 15 | GRK1 | 1.79602194 |
| 16 | EPHA3 | 1.76575953 |
| 17 | TNK2 | 1.76511341 |
| 18 | SIK2 | 1.71755604 |
| 19 | GRK6 | 1.66089814 |
| 20 | ADRBK2 | 1.60071639 |
| 21 | RIPK4 | 1.55075273 |
| 22 | TYK2 | 1.52620991 |
| 23 | NLK | 1.44337299 |
| 24 | DAPK2 | 1.43847131 |
| 25 | MAP3K7 | 1.40982592 |
| 26 | ITK | 1.36753176 |
| 27 | FGFR3 | 1.34768387 |
| 28 | ERBB2 | 1.32664991 |
| 29 | IKBKE | 1.28895368 |
| 30 | CASK | 1.26341657 |
| 31 | EPHA2 | 1.25127647 |
| 32 | MAP2K6 | 1.20875054 |
| 33 | SYK | 1.16921699 |
| 34 | MST4 | 1.13604292 |
| 35 | INSRR | 1.08359113 |
| 36 | PRKG2 | 1.07277756 |
| 37 | CDC42BPA | 1.06187762 |
| 38 | BTK | 1.06173115 |
| 39 | ZAP70 | 1.04887348 |
| 40 | EPHB1 | 1.04540800 |
| 41 | SIK3 | 1.02368783 |
| 42 | PRKCQ | 1.01072286 |
| 43 | CSK | 0.96141256 |
| 44 | TEC | 0.94479122 |
| 45 | LCK | 0.94143113 |
| 46 | IRAK1 | 0.93753611 |
| 47 | NME1 | 0.93047009 |
| 48 | MAPK13 | 0.89470602 |
| 49 | TNIK | 0.87847898 |
| 50 | KIT | 0.84878890 |
| 51 | LYN | 0.83709417 |
| 52 | CDK12 | 0.82369972 |
| 53 | MAPK11 | 0.81321579 |
| 54 | PTK2B | 0.81031981 |
| 55 | JAK1 | 0.79017243 |
| 56 | TYRO3 | 0.76616823 |
| 57 | WNK3 | 0.75494792 |
| 58 | PRKAA2 | 0.75348444 |
| 59 | PAK3 | 0.73865019 |
| 60 | MAP4K2 | 0.72720295 |
| 61 | FGFR2 | 0.71156144 |
| 62 | JAK3 | 0.70755077 |
| 63 | BLK | 0.70586922 |
| 64 | IKBKB | 0.70283026 |
| 65 | CAMKK1 | 0.70273792 |
| 66 | PTK6 | 0.70066089 |
| 67 | PRKCI | 0.69991578 |
| 68 | FES | 0.69118506 |
| 69 | PINK1 | 0.68883948 |
| 70 | MAP3K11 | 0.66758313 |
| 71 | PDK1 | 0.66732311 |
| 72 | PRKCH | 0.66188448 |
| 73 | ADRBK1 | 0.65120905 |
| 74 | MAP3K13 | 0.63353833 |
| 75 | MET | 0.62294602 |
| 76 | PRKCZ | 0.59869360 |
| 77 | CSF1R | 0.59726915 |
| 78 | FER | 0.56790966 |
| 79 | TBK1 | 0.54619612 |
| 80 | AKT3 | 0.53608855 |
| 81 | CAMKK2 | 0.51737004 |
| 82 | NUAK1 | 0.50881021 |
| 83 | HCK | 0.50857547 |
| 84 | NTRK3 | 0.50134143 |
| 85 | MAP3K2 | 0.50072103 |
| 86 | WNK1 | 0.48183166 |
| 87 | MAPK15 | 0.46321045 |
| 88 | MAP2K2 | 0.45863003 |
| 89 | MAPKAPK3 | 0.45451912 |
| 90 | STK11 | 0.45229035 |
| 91 | CHUK | 0.45052636 |
| 92 | FGR | 0.44800239 |
| 93 | MARK2 | 0.44096567 |
| 94 | PRKCA | 0.43329770 |
| 95 | STK24 | 0.40937169 |
| 96 | TLK1 | 0.40893539 |
| 97 | HIPK2 | 0.40356382 |
| 98 | SGK1 | 0.39396685 |
| 99 | IRAK4 | 0.38067572 |
| 100 | MAP3K1 | 0.36872400 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.59896831 |
| 2 | Caffeine metabolism_Homo sapiens_hsa00232 | 3.41822689 |
| 3 | Fat digestion and absorption_Homo sapiens_hsa04975 | 3.10860457 |
| 4 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 3.08145027 |
| 5 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.72637278 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.45215244 |
| 7 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.35030802 |
| 8 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.32630074 |
| 9 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.30615359 |
| 10 | Histidine metabolism_Homo sapiens_hsa00340 | 2.25049888 |
| 11 | Retinol metabolism_Homo sapiens_hsa00830 | 2.24585543 |
| 12 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.14822001 |
| 13 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.06286492 |
| 14 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.99655312 |
| 15 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.82122285 |
| 16 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.80204391 |
| 17 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.80076472 |
| 18 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.79232656 |
| 19 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.76154201 |
| 20 | Allograft rejection_Homo sapiens_hsa05330 | 1.75132244 |
| 21 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.74610380 |
| 22 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.74593778 |
| 23 | Mineral absorption_Homo sapiens_hsa04978 | 1.71065264 |
| 24 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.70651347 |
| 25 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.70039074 |
| 26 | Asthma_Homo sapiens_hsa05310 | 1.69629953 |
| 27 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.60657280 |
| 28 | ABC transporters_Homo sapiens_hsa02010 | 1.56690917 |
| 29 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.55297250 |
| 30 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.54638227 |
| 31 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.54598119 |
| 32 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.52758847 |
| 33 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.47040330 |
| 34 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.44814652 |
| 35 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.42984554 |
| 36 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.36212623 |
| 37 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.35243233 |
| 38 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.30819310 |
| 39 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.30752136 |
| 40 | Bile secretion_Homo sapiens_hsa04976 | 1.23272993 |
| 41 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.18488463 |
| 42 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.16240694 |
| 43 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.10262977 |
| 44 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.09504563 |
| 45 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.00228521 |
| 46 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.97972442 |
| 47 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.97544406 |
| 48 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.91764347 |
| 49 | Peroxisome_Homo sapiens_hsa04146 | 0.89639315 |
| 50 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.88506569 |
| 51 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.83275636 |
| 52 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.80921397 |
| 53 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.79683801 |
| 54 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.76392091 |
| 55 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.76152069 |
| 56 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.75556596 |
| 57 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.73487956 |
| 58 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.69869785 |
| 59 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.65756192 |
| 60 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.62483570 |
| 61 | Phototransduction_Homo sapiens_hsa04744 | 0.61427642 |
| 62 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.56942877 |
| 63 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.54185940 |
| 64 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.51229949 |
| 65 | Leishmaniasis_Homo sapiens_hsa05140 | 0.50088986 |
| 66 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.47727386 |
| 67 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.40842932 |
| 68 | Insulin secretion_Homo sapiens_hsa04911 | 0.40547025 |
| 69 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.39939250 |
| 70 | Insulin resistance_Homo sapiens_hsa04931 | 0.39520223 |
| 71 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.39045948 |
| 72 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.39045508 |
| 73 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.38868947 |
| 74 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.37220880 |
| 75 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.37130415 |
| 76 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.36226251 |
| 77 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.32880805 |
| 78 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.32657403 |
| 79 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.30922781 |
| 80 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.30689030 |
| 81 | Viral myocarditis_Homo sapiens_hsa05416 | 0.28644723 |
| 82 | Renin secretion_Homo sapiens_hsa04924 | 0.27750574 |
| 83 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.27218319 |
| 84 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.26689044 |
| 85 | Tuberculosis_Homo sapiens_hsa05152 | 0.26306867 |
| 86 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.24818024 |
| 87 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.24791482 |
| 88 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.24662831 |
| 89 | Metabolic pathways_Homo sapiens_hsa01100 | 0.22059062 |
| 90 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.21816581 |
| 91 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.21535659 |
| 92 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.20790775 |
| 93 | Hepatitis C_Homo sapiens_hsa05160 | 0.20780950 |
| 94 | Taste transduction_Homo sapiens_hsa04742 | 0.20591743 |
| 95 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.20409175 |
| 96 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.19893715 |
| 97 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.19654571 |
| 98 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.19628951 |
| 99 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.19408503 |
| 100 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.17990288 |

